ContraFect Corporation to Present at 12th Annual BIO Investor Forum
October 01, 2013 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Oct 1, 2013) - ContraFect Corporation announced that Dr. Robert Nowinski, the company's founder and chief executive officer, and Julia P. Gregory, the company's...
ContraFect Completes $11.8 Million Financing
September 04, 2013 10:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, is pleased to announce that it has successfully closed a...
ContraFect to Present at the 5th Annual Biotech Showcase
January 04, 2013 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Jan 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Robert Nowinski, the Company's founder...
ContraFect Announces Appointment of Sir Richard Sykes to Board of Directors
June 26, 2012 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Jun 26, 2012) - ContraFect Corporation announced today that Sir Richard Sykes, FRS, has joined the company's Board of Directors. Sir Richard has over 30 years of...
ContraFect Names Sol Barer Chairman of the Board
March 08, 2012 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Mar 8, 2012) - ContraFect Corporation announced today that Sol Barer, Ph.D. has been named the company's Chairman of the Board. Dr. Barer has been a director of...
ContraFect Corporation Completes Successful Pre-IND Meeting With FDA
December 14, 2011 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Dec 14, 2011) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug-resistant bacteria, completed a...